BCBN News

• 

  Opinion: Changing how buildings use energy can help combat climate change

  September 30, 2022 Comments Off on Opinion: Changing how buildings use energy can help combat climate change

• 

  Newton-Wellesley Hospital Nurses Vote for New Contract that Invests in Caregivers to Improve Patient Care and Help Overcome COVID-19 Staffing Impacts

  September 30, 2022 Comments Off on Newton-Wellesley Hospital Nurses Vote for New Contract that Invests in Caregivers to Improve Patient Care and Help Overcome COVID-19 Staffing Impacts

• 

  Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

  September 30, 2022 Comments Off on Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

• 

  Blue Cross Blue Shield of Massachusetts Expedites Access to Care for Members Affected by Hurricane Ian

  September 30, 2022 Comments Off on Blue Cross Blue Shield of Massachusetts Expedites Access to Care for Members Affected by Hurricane Ian

• 

  Op-ed: Biden’s premature declaration on the end of the COVID-19 pandemic

  September 30, 2022 Comments Off on Op-ed: Biden’s premature declaration on the end of the COVID-19 pandemic

• 

  Should women runners carry guns for self-defense?

  September 30, 2022 Comments Off on Should women runners carry guns for self-defense?

• 

  Results of the Insulin-Only Bionic Pancreas Pivotal Trial, Which Were Presented at ADA’s 82nd Scientific Sessions, Are Published This Week in the New England Journal of Medicine

  September 30, 2022 Comments Off on Results of the Insulin-Only Bionic Pancreas Pivotal Trial, Which Were Presented at ADA’s 82nd Scientific Sessions, Are Published This Week in the New England Journal of Medicine

• 

  EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing

  September 30, 2022 Comments Off on EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing

• 

  IMV Provides an Update on The VITALIZE Trial

  September 30, 2022 Comments Off on IMV Provides an Update on The VITALIZE Trial

• 

  ‘Don’t eat me’ upstart taps Takeda vet on path to the clinic; Greg Mayes leaves Antios for Canadian psychedelics player

  September 30, 2022 Comments Off on ‘Don’t eat me’ upstart taps Takeda vet on path to the clinic; Greg Mayes leaves Antios for Canadian psychedelics player